Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5698)
All Articles published online
|
Publishing Process of This Article
|
Sep 24, 2019 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhou J, Chng WJ. Novel mechanism of drug resistance to proteasome inhibitors in multiple myeloma. World J Clin Oncol 2019; 10(9): 303-306 [PMID: 31572666 DOI: 10.5306/wjco.v10.i9.303] |
|---|---|
| URL: | https://www.wjgnet.com/2222-0682/full/v10/i9/303.htm |
| Number | Citing Articles |
| 1 |
Yang Bai, Xing Su. Updates to the drug‐resistant mechanism of proteasome inhibitors in multiple myeloma. Asia-Pacific Journal of Clinical Oncology 2021; 17(1): 29 doi: 10.1111/ajco.13459
|
| 2 |
Dong Wu, Jiyu Miao, Jinsong Hu, Fangmei Li, Dandan Gao, Hongli Chen, Yuandong Feng, Ying Shen, Aili He. PSMB7 Is a Key Gene Involved in the Development of Multiple Myeloma and Resistance to Bortezomib. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.684232
|
| 3 |
Guoyuan Tang, Shan Huang, Ji Luo, Yingmiao Wu, Shuai Zheng, Rongsheng Tong, Ling Zhong, Jianyou Shi. Advances in research on potential inhibitors of multiple myeloma. European Journal of Medicinal Chemistry 2023; 262: 115875 doi: 10.1016/j.ejmech.2023.115875
|
| 4 |
Satyendra Chandra Tripathi, Disha Vedpathak, Edwin Justin Ostrin. The Functional and Mechanistic Roles of Immunoproteasome Subunits in Cancer. Cells 2021; 10(12): 3587 doi: 10.3390/cells10123587
|
| 5 |
Sinan Xiong, Wee-Joo Chng, Jianbiao Zhou. Crosstalk between endoplasmic reticulum stress and oxidative stress: a dynamic duo in multiple myeloma. Cellular and Molecular Life Sciences 2021; 78(8): 3883 doi: 10.1007/s00018-021-03756-3
|
| 6 |
Ana Savia Cardoso Brito, Gildeanni Iasmim Alves Vieira, Alessandra Souza dos Santos, Aroldo Mazur Barbosa da Silva. PROBIÓTICOS NO TRATAMENTO DO MIELOMA MÚLTIPLO: UMA REVISÃO. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218 2024; 5(6): e565340 doi: 10.47820/recima21.v5i6.5340
|
| 7 |
Miao Yuan, Hanwen Ji, Fengxin Sun, Qiang Chen, Ping Cheng. Rational design of novel phenol ether derivatives as non-covalent proteasome inhibitors through 3D-QSAR, molecular docking and ADMET prediction. Exploration of Drug Science 2023; : 435 doi: 10.37349/eds.2023.00029
|
| 8 |
Joelle C. Boulos, Mohamed E. M. Saeed, Manik Chatterjee, Yagmur Bülbül, Francesco Crudo, Doris Marko, Markus Munder, Sabine M. Klauck, Thomas Efferth. Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells. Pharmaceuticals 2021; 14(11): 1126 doi: 10.3390/ph14111126
|
| 9 |
Noa Biran,, Pooja Phull,, Andre Goy. Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies. 2023; : 331 doi: 10.1002/9781119819950.ch24
|